Home - VaccineNationLatest news and insights into the world of vaccines from the World Vaccine Congress, as well as details on our events.Home - VaccineNation Therapeutic Technology Infection Global Health Events >> Get Our Newsletters Select Page IFFIm: $1 billion to support global vaccine programmes by Charlotte Kilpatrick | Oct 24, 2024In October 2024 the International Finance Facility for Immunisation (IFFIm) priced a US$1 billion, 3-year fixed-rate bond to fund “critical vaccine research and immunisation programmes”. This is IFFIm’s largest single benchmark transaction in the primary market since... Study: vaccinating children against mpox “most efficient” by Charlotte Kilpatrick | Oct 23, 2024A study in The Lancet Global Health sought to provide counterfactual scenarios to evaluate the short-term effects of different vaccination strategies on mpox cases and deaths in the Democratic Republic of the Congo (DRC). The researchers used a dynamic transmission... Microneedle technology wins Gates grants of $6.6 million by Charlotte Kilpatrick | Oct 24, 2024 | TechnologyThe University of Connecticut (UConn) announced in October 2024 that associate Professor Thanh Nguyen’s research has received “significant” UK begins Phase III trial of mRNA norovirus vaccine Oct 23, 2024The National Institute for Health and Care Research (NIHR) announced in October 2024 that the first Phase III randomised trial of an investigational WHO declares Egypt malaria-free after 100-year effort Oct 21, 2024In October 2024 WHO certified Egypt as malaria-free after a “nearly 100-year effort” by the government and people to end the disease. WHO described Bacterial vectors for precision cancer vaccine development Oct 21, 2024Research in Nature in October 2024 leverages evidence that bacteria “naturally home in on tumours and modulate antitumour immunity” to explore Global Polio Eradication Initiative faces challenges Oct 18, 2024The Global Polio Eradication Initiative (GPEI) announced the “difficult decision” to extend the timelines needed to achieve polio eradication. The Vaccine Group and APHA secure animal vaccine grant Oct 18, 2024In October 2024 the Animal and Plant Health Agency (APHA) and The Vaccine Group (TVG) announced that Innovate UK has awarded them a Smart Valneva and LimmaTech secure Shigella vaccine fast track Oct 17, 2024Valneva and LimmaTech Biologics announced in October 2024 that they have been granted Fast Track designation by the United States FDA for Shigella4V THERAPEUTIC Bacterial vectors for precision cancer vaccine development Research in Nature in October 2024 leverages evidence that bacteria “naturally home in on tumours and modulate antitumour immunity” to explore Transgene shares “disappointing” TG4001 study update Transgene announced in October 2024 that the primary objective of its randomised Phase II study of TG4001 has not been met. The study was evaluating Study: cancer vaccine could tackle lesions if used early A study in the Journal for ImmunoTherapy of Cancer finds that vaccination in a clinically relevant genetic cancer mouse model generated a population Gritstone’s data “encouraging”, but are they enough? Interim Phase II data from Gritstone bio’s study evaluating GRANITE in September 2024 are described as “encouraging” in a company statement. DNA vaccines show promise against multiple myeloma In an article for npj vaccines in October 2024, researchers present their investigation into the efficacy of a combination of DNA vaccine encoding mouse GPRC5D TECHNOLOGY Microneedle technology wins Gates grants of $6.6 million The University of Connecticut (UConn) announced in October 2024 that associate Professor Thanh Nguyen’s research has received “significant” UK begins Phase III trial of mRNA norovirus vaccine The National Institute for Health and Care Research (NIHR) announced in October 2024 that the first Phase III randomised trial of an investigational The Vaccine Group and APHA secure animal vaccine grant In October 2024 the Animal and Plant Health Agency (APHA) and The Vaccine Group (TVG) announced that Innovate UK has awarded them a Smart Valneva and LimmaTech secure Shigella vaccine fast track Valneva and LimmaTech Biologics announced in October 2024 that they have been granted Fast Track designation by the United States FDA for Shigella4V CEPI and NRC work on safe protein antigens, faster CEPI announced in October 2024 that it is working with experts at the National Research Council of Canada (NRC) to bioengineer a “commonly INFECTION Three human cases of H5 bird flu reported in California In October 2024, the United States CDC reported a third human case of H5 bird flu in the state of California. This announcement followed the identification WHO mpox update: 14 countries in “active” outbreaks A recent WHO situation report on the mpox PHEIC reveals that 14 countries on the continent have reported mpox cases in the last six weeks and are As Rwanda’s Marburg outbreak worsens, Hamburg sounds alarm After the announcement of an outbreak of Marburg virus in Rwanda in September 2024 and the initiation of response efforts, reports of suspected Rwanda reports its first Marburg outbreak with six deaths In September 2024 WHO’s Regional Office for Africa announced that Rwandan health authorities are “intensifying outbreak control efforts” after detecting Marburg Chikungunya in India has a “notorious edge this year” The Times of India reported in September 2024 that cases of chikungunya in children were symptomatic of a “shift” in epidemiology. Case numbers GLOBAL HEALTH IFFIm: $1 billion to support global vaccine programmes In October 2024 the International Finance Facility for Immunisation (IFFIm) priced a US$1 billion, 3-year fixed-rate bond to fund “critical vaccine Study: vaccinating children against mpox “most efficient” A study in The Lancet Global Health sought to provide counterfactual scenarios to evaluate the short-term effects of different vaccination strategies WHO declares Egypt malaria-free after 100-year effort In October 2024 WHO certified Egypt as malaria-free after a “nearly 100-year effort” by the government and people to end the disease. WHO described Global Polio Eradication Initiative faces challenges The Global Polio Eradication Initiative (GPEI) announced the “difficult decision” to extend the timelines needed to achieve polio eradication. Modelling study: 100 Days Mission demands vaccine equity A study in The Lancet Global Health estimates the impact that the 100 Days Mission could have had on the COVID-19 pandemic. The authors Follow us! FollowFollowFollowFollow Resources NewsletterEventsVideo Company About us Contact us Advertise / Exhibit VaccineNation - Strategy & Innovation in Vaccinesenusen-US1771970401https://vaccinenation.org